PBM

Psyence Biomedical Ltd. Common Shares

NASDAQ: PBM · HEALTHCARE · BIOTECHNOLOGY

$5.27

-6.58% today

Updated 2026-06-04

Market cap

$7.64M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-389.98

Dividend yield

—

52W range

$2 – $75

Volume

3.0M

Market cap

$7.64M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-389.98

Dividend yield

—

52W range

$2 – $75

Volume

3.0M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.8

Quality

C+

3.0

Profitability

5.0

Valuation

C+

4/9

Piotroski F-Score

Moderate

-2.6

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Altman Z -2.58 — distress zone

- Thin margins at 0.00%

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$8.23M	$8.01M	$-51.16M	$1.01M	$-753254.00
EPS	—	—	—	—	$-389.98
Free cash flow	$-1.07M	$-2153.00	$-2.95M	$-3.74M	—
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
PBM	$7.64M	26	4.3	3.0	5.0	5.8	—	Avoid
LLY	$948.95B	78	10.0	10.0	5.0	6.0	—	Strong Buy
JNJ	$536.54B	59	4.7	9.0	3.3	6.0	-71.41%	Buy
ABBV	$380.57B	63	4.0	8.0	4.0	5.0	-55.64%	Buy
UNH	$343.21B	54	5.3	5.5	4.7	5.5	-26.61%	Buy
MRK	$285.64B	50	3.3	8.0	2.7	5.0	-49.34%	Hold

Smart narrative

Psyence Biomedical Ltd. Common Shares trades at $5.27. Our Smart Value Score of 26/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -2.58, it sits in the distress.

Frequently asked questions

What is Psyence Biomedical Ltd. Common Shares's stock price?

Psyence Biomedical Ltd. Common Shares (PBM) trades at $5.27.

Is Psyence Biomedical Ltd. Common Shares overvalued?

Psyence Biomedical Ltd. Common Shares carries a Smart Value Score of 26/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Psyence Biomedical Ltd. Common Shares's Altman Z-Score is -2.58, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-74.30%

Beta1.65

50D MA$4.85

200D MA$51.63

Shares out0.00B

Float0.00B

Short ratio—

Avg volume3.0M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

PBM vs LLY →PBM vs JNJ →PBM vs ABBV →Stock screener →